Strategic Partnerships for Global Impact
Strong & Meaningful Partnerships
Driving Innovation Through Global Partnerships and Networks
At Vactech, we prioritize strong, meaningful partnerships. Our longstanding collaborations with both academia and industry ensure reliable, high-quality results and compatibility with global pharmaceutical standards. Thanks to our leadership’s extensive professional networks, we maintain direct connections with leading scientific communities and influential Key Opinion Leaders worldwide, continually enhancing our innovation capabilities and global reach.
“Through its innovative approach and strategic partnerships with prominent pharmaceutical firms, biotech companies, and leading academic institutions, Vactech has firmly established itself as a pioneer in preventive solutions for type 1 diabetes. These key collaborations have significantly accelerated the advancement of vaccine candidates into clinical trials, reinforcing Vactech’s global leadership role in tackling type 1 diabetes and related diseases.” Petri Laine - Partner, Innovestor Venture Capital
Stronger Together
Cooperation With
Academic Groups
and Industrial Partners
Vactech collaborates closely with leading international academic institutions and industry partners, adhering strictly to Good Laboratory Practices (GLP) and Good Clinical Practices (GCP). Our strong experience in preclinical and clinical research together with established collaboration networks creates a solid basis for effective development of our assets and conduction of preclinical and clinical trials.
